Protease inhibitors do not affect antibody responses to pneumococcal vaccination

Indhira De La Rosa, Iona M. Munjal, Maria Rodriguez-Barradas, Xiaoying Yu, Liise Anne Pirofski, Daniel Mendoza

Research output: Contribution to journalArticle

Abstract

HIV+ subjects on optimal antiretroviral therapy have persistently impaired antibody responses to pneumococcal vaccination. We explored the possibility that this effect may be due to HIV protease inhibitors (PIs). We found that in humans and mice, PIs do not affect antibody production in response to pneumococcal vaccination.

Original languageEnglish (US)
Pages (from-to)524-529
Number of pages6
JournalClinical and Vaccine Immunology
Volume23
Issue number6
DOIs
StatePublished - Jun 1 2016
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Clinical Biochemistry
  • Microbiology (medical)

Cite this

De La Rosa, I., Munjal, I. M., Rodriguez-Barradas, M., Yu, X., Pirofski, L. A., & Mendoza, D. (2016). Protease inhibitors do not affect antibody responses to pneumococcal vaccination. Clinical and Vaccine Immunology, 23(6), 524-529. https://doi.org/10.1128/CVI.00026-16